Curam Duo 400 57 Powder for Oral Suspension

Official notice

27 May 2019

Last checked

27 May 2019

Risk not stated by sourceACCC

An official ACCC notice concerns Curam Duo 400 57 Powder for Oral Suspension. Over time, this may result in the significant degradation of the active ingredients and the production of related impurities. This may mean that the product has reduced effectiveness and patients may also be at risk of developing antimicrobial resistance. The risk of adverse events is considered to be higher for children than for adults. Published 2019-05-27.

What to do now

If you or someone you provide care for takes Curam Duo 400/57, check the batch number. If your medicine has batch number JC5418 or JC5419 (both with expiry date July 2021), stop using it immediately and return it to your pharmacy for a refund. Alternatively, you can call Sandoz Australia on 1800 726 369 to arrange the return of the affected product and a refund. You may need to discuss ongoing treatment with your doctor, particularly if you or your child have not completed the antibiotic course as prescribed. If you have any further questions or concerns about this issue, talk to your health professional.

Recall number

bfc2b7ef-ac42-4b35-85cf-bc7817840b95

Official notice

2019-05-27

The hazard

Over time, this may result in the significant degradation of the active ingredients and the production of related impurities. This may mean that the product has reduced effectiveness and patients may also be at risk of developing antimicrobial resistance. The risk of adverse events is considered to be higher for children than for adults.

How to check if you're affected

Compare the product name and identifiers below with the item you own. Follow the official notice if they match.

Lots

es, JC5418

Checked manually this time?

The app alerts you when a new official recall is published — no searching, no checking back.

Turn on recall alerts

Affected products

Product 1

Curam Duo is a prescription medicine that contains a type of antibiotic called amoxicillin, as well as a second active ingredient called potassium clavulanate. It is a powder for oral suspension (60 mL liquid when mixed) that is used to treat a wide range of infections caused by bacteria in adults and children. Affected batches JC5418 and JC5419 only Expiry date July 2021 ARTG: AUST R 147109

Risk / hazard

Over time, this may result in the significant degradation of the active ingredients and the production of related impurities. This may mean that the product has reduced effectiveness and patients may also be at risk of developing antimicrobial resistance. The risk of adverse events is considered to be higher for children than for adults.

Where it was sold

The source does not list specific retailers. See the official notice for where affected products were sold.

Location 1

AU · Australia

Affected area 1

AU · Australia

Source & status

Source

Tier

beta

Category

HOME

Classification

Pharmacy and medical products

App estimate

unspecified

Recall details

Recall number

bfc2b7ef-ac42-4b35-85cf-bc7817840b95

Classification

Pharmacy and medical products

Source tier

beta

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 27 May 2019. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.